Overall rank by patents
#18,728
of 50,000 tracked assignees
USPTO PatentsView assignee record - 15 granted patents across 13 technology areas, recorded in grant years 2023–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07H (SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS).
The verdict
According to USPTO PatentsView, Hongene ranks #18,728 of 50,000 tracked US assignees by granted-patent volume, with 15 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R18728 · US Corporation #18,728 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Holaira, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Benteler Automobilte… · near
57 score
Hongene Biotech · this assignee
57 score
Navico Holding AS · near
57 score
THE University OF Ak… · near
57 score
Wayne Fueling Systems · near
57 score
3D Lighting Innovati… · lowest
7 score
What this shows Hongene Biotech Corporation stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #18,728 of 50,000; Innovation Score 57.3/100 sits in the top 5% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Holaira, Inc. (±0 grants).
Hongene Biotech Corporation has been granted 15 US utility patents between 2023 and 2024, placing Hongene Biotech Corporation at #18,728 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.7 claims per patent with primary concentration in C07H (SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS). As a US Corporation, Hongene Biotech Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Hongene sits between Holaira, Inc. (15 patents, rank #18,728) and House Of Design Llc (15 patents, rank #18,736) - the closest US assignees by grant volume. The composite Innovation Score of 57.3/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2023 through 2024, with 15 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Hongene Biotech Corporation's 28.7 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 13 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Holaira, Inc.
15 patents
Homax Products, Inc.
15 patents
Honda elesys Co., Ltd.
15 patents
Hong Kong IVPS International Limited
15 patents
Hoshizaki America, Inc.
15 patents
Hospital for Special Surgery
15 patents
Houghton Mifflin Harcourt Publishing Company
15 patents
House of Design LLC
15 patents
Hongene Biotech Corporation
15 patents
What this shows Hongene holds 15 patents at rank #18,732, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #18,732 in granted patent volume.
Other assignees with the most granted patents in Hongene's primary technology class.
Two PlainPatent-derived peer sets for Hongene, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (57 here).
Hongene's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
57 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 5 | 33.3% |
| 2024 | 10 | 66.7% |
Top 13 of 13 technology areas
Overall rank by patents
#18,728
of 50,000 tracked assignees
57.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.